162 related articles for article (PubMed ID: 38056801)
1. Expanding Role of Gastroenterology in the Staging of Digestive Neuroendocrine Tumors: Updates From the American Joint Committee on Cancer Version 9 Cancer Staging System.
Ge PS; Shi C; Asare E; Washington MK; O'Toole D;
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):448-451. PubMed ID: 38056801
[No Abstract] [Full Text] [Related]
2. Validation of the Novel Eighth Edition of American Joint Committee on Cancer Staging Manual: An In-depth Analysis for Nonfunctional Pancreatic Neuroendocrine Neoplasms.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Pancreas; 2020; 49(5):e42-e43. PubMed ID: 32433414
[No Abstract] [Full Text] [Related]
3. [Standardization in diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms: the Chinese consensus].
Chinese pathologic consensus group for gastrointestinal and pancreatic neuroendocrine neoplasms
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):691-4. PubMed ID: 24439254
[No Abstract] [Full Text] [Related]
4. Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.
McDermott S; O'Neill AC; Skehan SJ
Clin Imaging; 2013; 37(2):194-200. PubMed ID: 23465968
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
6. [Proposal for a TNM classification of digestive (neuro)endocrine tumors: recommendations of the European Neuroendocrine Tumor Society (2006)].
Couvelard A; Scoazec JY
Ann Pathol; 2006 Dec; 26(6):413-7. PubMed ID: 17255899
[No Abstract] [Full Text] [Related]
7. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
9. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
Choe J; Kim KW; Kim HJ; Kim DW; Kim KP; Hong SM; Ryu JS; Tirumani SH; Krajewski K; Ramaiya N
Korean J Radiol; 2019 Jan; 20(1):5-17. PubMed ID: 30627018
[TBL] [Abstract][Full Text] [Related]
10. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
11. Gastroenteropancreatic neuroendocrine tumors in children and young adults.
Khanna G; O'Dorisio SM; Menda Y; Kirby P; Kao S; Sato Y
Pediatr Radiol; 2008 Mar; 38(3):251-9, quiz 358-9. PubMed ID: 17906857
[TBL] [Abstract][Full Text] [Related]
12. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].
Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402
[No Abstract] [Full Text] [Related]
13. [The latest 2010 WHO classification of tumors of digestive system].
Li ZS; Li Q
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):351-4. PubMed ID: 21756837
[No Abstract] [Full Text] [Related]
14. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
[TBL] [Abstract][Full Text] [Related]
15. The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer: A Review and Update.
Liao X; Zhang D
Arch Pathol Lab Med; 2021 May; 145(5):543-553. PubMed ID: 32223559
[TBL] [Abstract][Full Text] [Related]
16. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.
Strosberg JR; Cheema A; Weber J; Han G; Coppola D; Kvols LK
J Clin Oncol; 2011 Aug; 29(22):3044-9. PubMed ID: 21709192
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
Oberg K
Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine Neoplasia of the digestive tract].
Begum N; Anlauf M
Ther Umsch; 2020 Nov; 77(9):449-455. PubMed ID: 33146094
[TBL] [Abstract][Full Text] [Related]
19. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a closer look at the characteristics of these diverse tumors.
Pape UF
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):8-11. PubMed ID: 25768103
[No Abstract] [Full Text] [Related]
20. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
